Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 0 |
Since 2016 (last 10 years) | 0 |
Since 2006 (last 20 years) | 2 |
Descriptor
Alzheimers Disease | 3 |
Older Adults | 3 |
Brain | 2 |
Neurological Impairments | 2 |
Aging (Individuals) | 1 |
Attention | 1 |
Cognitive Ability | 1 |
Cognitive Processes | 1 |
Comparative Analysis | 1 |
Control Groups | 1 |
Drug Therapy | 1 |
More ▼ |
Source
Brain | 3 |
Author
Bird, Thomas D. | 1 |
Dickerson, Kathryn | 1 |
Duffy, Charles J. | 1 |
Flashman, Laura A. | 1 |
Jayadev, Suman | 1 |
Klunk, William | 1 |
Leverenz, James B. | 1 |
Mamourian, Alexander C. | 1 |
Mapstone, Mark | 1 |
McHugh, Tara L. | 1 |
Rabin, Laura A. | 1 |
More ▼ |
Publication Type
Journal Articles | 3 |
Reports - Research | 3 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Jayadev, Suman; Leverenz, James B.; Steinbart, Ellen; Stahl, Justin; Klunk, William; Yu, Cheng-En; Bird, Thomas D. – Brain, 2010
Mutations in presenilin 2 are rare causes of early onset familial Alzheimer's disease. Eighteen presenilin 2 mutations have been reported, although not all have been confirmed pathogenic. Much remains to be learned about the range of phenotypes associated with these mutations. We have analysed our unique collection of 146 affected cases in 11…
Descriptors: Alzheimers Disease, Seizures, Genealogy, German
Mapstone, Mark; Dickerson, Kathryn; Duffy, Charles J. – Brain, 2008
Similar manifestations of functional decline in ageing and Alzheimer's disease obscure differences in the underlying cognitive mechanisms of impairment. We sought to examine the contributions of top-down attentional and bottom-up perceptual factors to visual self-movement processing in ageing and Alzheimer's disease. We administered a novel…
Descriptors: Alzheimers Disease, Aging (Individuals), Older Adults, Cognitive Ability
Saykin, Andrew J.; Wishart, Heather A.; Rabin, Laura A.; Flashman, Laura A.; McHugh, Tara L.; Mamourian, Alexander C.; Santulli, Robert B. – Brain, 2004
Cholinesterase inhibitors positively affect cognition in Alzheimer's disease (AD) and other conditions, but no controlled functional MRI studies have examined where their effects occur in the brain. We examined the effects of donepezil hydrochloride (Aricept[Registered sign]) on cognition and brain activity in patients with amnestic mild cognitive…
Descriptors: Patients, Memory, Brain, Alzheimers Disease